packageApremilast

apremilast

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Apremilast is an immunosuppressant used to treat inflammatory conditions such as psoriasis, psoriatic arthritis, and Behçet's disease. It is an approved medicine, authorised in the European Union, and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q2858961 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:apremilast
ATC codes:L04AA32
DrugBank:DB05676
PubChem CID:11561674
ChEBI:78540
Wikidata:Q2858961
formula:C22H24N2O7S
molar mass:460.501 g/mol (PubChem CID 11561674)
logP:1.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown